Epinephrine, Norepinephrine, Glucagon, and Growth Hormone Release in Association with Physiological Decrements in the Plasma Glucose Concentration in Normal and Diabetic Man*
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The release of potentially important glucose counter-regulatory factors (epinephrine, norepinephrine, glucagon, GH, and cortisol) was studied during Biostator-controlled reductions in the plasma glucose concentration from the high physiological level of 95 mg/dl to the low physiological level of 60 mg/dl in 10 subjects (5 normal subjects and 5 patients with insulin-dependent diabetes) and from the supraphysiological level of 200 to 100 mg/dl in 6 subjects (3 normal subjects and 3 patients with insulin-dependent diabetes). Reductions in the plasma glucose concentration from 95 to 60 mg/dl were associated with early (+30 to +40 min) increments [here with the maximal values expressed as the percent of the mean baseline (mean ± SE)] in plasma epinephrine (529 ± 144; P < 0.02), norepinephrine (146 ± 12; P < 0.01), and glucagon (123 ± 13; P < 0.05) and a late (+75 min) increment in plasma GH (2504 ± 1065; P < 0.05); an apparent late (+105 min) increment in plasma cortisol (132 ± 15) was not statistically significant. Reductions of the plasma glucose concentrations from 200 to 100 mg/dl were associated with smaller, but significant, increments in plasma epinephrine, norepinephrine, glucagon, and GH, an observation confirmed by study of additional normal subjects. Other than the fact that the nondiabetic group, but not the diabetic group, exhibited significant increments in plasma glucagon, systematic differences between patients with diabetes and subjects without diabetes were not d…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on hypoglycaemic glucose clamp studies dating back to the 1980s, it is commonly assumed that the physiological response to hypoglycaemia in healthy people occurs at glucose levels below 3.9 mmol/l, with the release of glucagon and adrenaline, whereas glucose levels below 3.3–3.5 mmol/l are reported to trigger symptomatic awareness [72].”
From Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review (2022) · cites this paper as [72]
Citations
Cites
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109840 · Cited by 576
Self-citationRole of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109464 · Cited by 421
Self-citationGarber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationNorepinephrine: hormone and neurotransmitter in man.
Silverberg, A. B., Shah, S. D., Haymond, M. W., & Cryer, P. E. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.234.3.e252 · Cited by 338
Self-citationHormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., & Cryer, P. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.4.e380 · Cited by 183
Self-citationSaccà, L., Sherwin, R., Hendler, R., & Felig, P. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109384 · Cited by 162
CRYER, P. E., SANTIAGO, J. V., & SHAH, S. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-6-1025 · Cited by 155
Self-citationHYPERGLYCEMIA INHIBITS GLUCOSE PRODUCTION IN MAN INDEPENDENT OF CHANGES IN GLUCOREGULATORY HORMONES
SACCA, L., HENDLER, R., & SHERWIN, R. S. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-5-1160 · Cited by 151
Closed-loop and Open-loop Devices for Blood Glucose Control in Normal and Diabetic Subjects
Santiago, J. V., Clemens, A. H., Clarke, W. L., & KIPNIS, D. M. (1978) · Diabetes · doi:10.2337/diab.28.1.71 · Cited by 134
Self-citationGlucose Disposal during Insulinopenia in Somatostatin-Treated Dogs
Shulman, G. I., Liljenquist, J. E., Williams, P. E., Lacy, W. W., & Cherrington, A. D. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109150 · Cited by 126
Characterization of the Glucagon Response to Hypoglycemia in Man
GERICH, J. E., SCHNEIDER, V., DIPPE, S. E., LANGLOIS, M., NOACCO, C., KARAM, J. H., & FORSHAM, P. H. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-1-77 · Cited by 120
DeFronzo, R. A., Hendler, R., & Christensen, N. (1980) · Diabetes · doi:10.2337/diab.29.2.125 · Cited by 119
HYPERGLYCEMIA PER SE (INSULIN AND GLUCAGON WITHDRAWN) CAN INHIBIT HEPATIC GLUCOSE PRODUCTION IN MAN
Liljenquist, J. E., Mueller, G. L., Cherrington, A. D., Perry, J. M., & Rabinowitz, D. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-1-171 · Cited by 101
Glucagon and Catecholamine Secretion During Hypoglycemia in Normal and Diabetic Man
BENSON, J. W., JOHNSON, D. G., PALMER, J. P., WERNER, P. L., & ENSINCK, J. W. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-3-459 · Cited by 84
Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma
Leichter, S. B., Pagliara, A. S., Greider, M. H., Pohl, S. L., Rosaí, J., & KIPNIS, D. M. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90579-3 · Cited by 75
Beitins, I. Z., Shaw, M. H., Kowarski, A. A., & Migeon, C. J. (1970) · Steroids · doi:10.1016/s0039-128x(70)80045-9 · Cited by 61
Counterregulatory Hormonal Responses to Rapid Glucose Lowering in Diabetic Man
Lilavivathana, U., Brodows, R. G., Woolf, P. D., & Campbell, R. G. (1979) · Diabetes · doi:10.2337/diab.28.10.873 · Cited by 57
Saccà, L., Cryer, P. E., & Sherwin, R. S. (1979) · Diabetes · doi:10.2337/diab.28.6.533 · Cited by 47
Self-citationDefective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.
Campbell, L. V., Kraegen, E. W., & Lazarus, L. (1977) · BMJ · doi:10.1136/bmj.2.6101.1527 · Cited by 41
Hypoglycemic Threshold for Human Growth Hormone Release
GLICK, S. M. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-5-619 · Cited by 36
The Characteristics of a New Glucose Sensor for Use in an Artificial Pancreatic Beta Cell
Clarke, W. L., & Santiago, J. V. (1977) · Artificial Organs · doi:10.1111/j.1525-1594.1977.tb00982.x · Cited by 29
Self-citationImportance of glucagon in regulatory rather than emergency responses to hypoglycemia
Gauthier, C., Vranic, M., & Hetenyi, G. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.2.e131 · Cited by 28
Galvanic Skin Reflex and Plasma Free Fatty Acids During Insulin Reactions
Bolinger, R. E., Stephens, R., Lukert, B. P., et al. (1964) · Diabetes · doi:10.2337/diab.13.6.600 · Cited by 20
PROGRESS OF MEDICAL SCIENCE: MEDICINE
Sodeman, W. A., Fabrykant, M., & Bruger, M. (1948) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194807000-00013 · Cited by 16
Clarke, W. L., Thomas, L. L., & Santiago, J. V. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80508-8 · Cited by 14
Self-citation
Cited by
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Mitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Self-citationService, F. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321707 · Cited by 503
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483
“As previously observed (35, 36), such a release of epinephrine suggests that in chronically hyperglycemic persons, a rapid lowering of glucose levels may cause counterregulatory hormone release even though glucose levels are not in the range that is usually considered hypoglycemic.”
BackgroundWhite, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Self-citation
Metadata
- Authors
- SANTIAGO, J. V., CLARKE, W. L., SHAH, S. D., & CRYER, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1980-10
- Volume
- 51
- Issue
- 4
- Pages
- 877-883
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2039781946
- Cited by
- 166
- References
- 27
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- epinephrine, norepinephrine, glucagon, growth hormone, cortisol, hypoglycemia, type 1 diabetes, hyperglycemia, diabetes mellitus, glucocorticoids, catecholamines
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Epinephrine, Glucagon, Glucose, Humans, Hydrocortisone, Insulin, Kinetics, Norepinephrine, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.